Prediction of severe adverse events, modes of action and drug treatments for COVID-19's complications.

Abstract excerpt

Following SARS-CoV-2 infection, some COVID-19 patients experience severe host driven adverse events. To treat these complications, their underlying etiology and drug treatments must be identified. Thus, a novel AI methodology MOATAI-VIR, which predicts disease-protein-pathway relationships and repurposed FDA-approved drugs to treat COVID-19's clinical manifestations was developed. SARS-CoV-2 interacting human...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Benchmarking
• Share to Comorbidity
• Share to COVID-19 Drug Treatment
• Share to Drug Discovery